Cargando…
Oncogenic KRAS: Signaling and Drug Resistance
SIMPLE SUMMARY: KRAS is one of the oncogenic proteins and best well-known GTPase proteins. Although KRAS serves as regulation of cellular process, abnormal mutated and GTP-bound KRAS is highly expressed in human cancers. Understanding biological characteristics and precise signaling of KRAS proteins...
Autores principales: | Kim, Hyeon Jin, Lee, Han Na, Jeong, Mi Suk, Jang, Se Bok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616169/ https://www.ncbi.nlm.nih.gov/pubmed/34830757 http://dx.doi.org/10.3390/cancers13225599 |
Ejemplares similares
-
Understand KRAS and the Quest for Anti-Cancer Drugs
por: Han, Chang Woo, et al.
Publicado: (2021) -
Structure, signaling and the drug discovery of the Ras oncogene protein
por: Han, Chang Woo, et al.
Publicado: (2017) -
A H-REV107 Peptide Inhibits Tumor Growth and Interacts Directly with Oncogenic KRAS Mutants
por: Han, Chang Woo, et al.
Publicado: (2020) -
Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule Drugs
por: Kim, Hyeon Jin, et al.
Publicado: (2021) -
Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors
por: Kim, Hyeon Jin, et al.
Publicado: (2021)